← Back to Search

cell therapy for Cardiovascular Disease

Phase 2 & 3
Waitlist Available
Led By Amit N. Patel, MD, MS
Research Sponsored by Amit N. Patel MD MS
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.

Eligible Conditions
  • Cardiovascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety - MACE - Death, Readmission, Reintervention

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: cell therapyExperimental Treatment1 Intervention
Patient receiving active biologic
Group II: controlPlacebo Group1 Intervention
Patient receiving placebo or standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cell therapy
2012
Completed Phase 3
~3800

Find a Location

Who is running the clinical trial?

Amit N. Patel MD MSLead Sponsor
Amit N. Patel, MD, MSPrincipal InvestigatorUniversity of Utah

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com
Amit N. Patel MD MS 2002. "Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00130377.
All > Cardiovascular
~44 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top